CN112956473A - Artificial transparent belt and preparation method thereof - Google Patents
Artificial transparent belt and preparation method thereof Download PDFInfo
- Publication number
- CN112956473A CN112956473A CN202110260524.4A CN202110260524A CN112956473A CN 112956473 A CN112956473 A CN 112956473A CN 202110260524 A CN202110260524 A CN 202110260524A CN 112956473 A CN112956473 A CN 112956473A
- Authority
- CN
- China
- Prior art keywords
- sperm
- artificial
- preparation
- solution
- polyornithine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims description 26
- 210000004340 zona pellucida Anatomy 0.000 claims abstract description 50
- 229920002714 polyornithine Polymers 0.000 claims abstract description 34
- 108010055896 polyornithine Proteins 0.000 claims abstract description 34
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000661 sodium alginate Substances 0.000 claims abstract description 22
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 22
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 22
- 239000004005 microsphere Substances 0.000 claims description 62
- 239000000017 hydrogel Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 21
- 239000000648 calcium alginate Substances 0.000 claims description 18
- 235000010410 calcium alginate Nutrition 0.000 claims description 18
- 229960002681 calcium alginate Drugs 0.000 claims description 18
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 18
- 239000001509 sodium citrate Substances 0.000 claims description 15
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 15
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 13
- 239000012528 membrane Substances 0.000 claims description 12
- 229920000867 polyelectrolyte Polymers 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002131 composite material Substances 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 3
- 238000001879 gelation Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 55
- 238000005138 cryopreservation Methods 0.000 description 52
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 32
- 238000007710 freezing Methods 0.000 description 18
- 230000008014 freezing Effects 0.000 description 18
- 239000007788 liquid Substances 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 16
- 238000011084 recovery Methods 0.000 description 16
- 206010003883 azoospermia Diseases 0.000 description 12
- 235000013601 eggs Nutrition 0.000 description 11
- 238000000520 microinjection Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000969 carrier Substances 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 230000002381 testicular Effects 0.000 description 7
- 230000002308 calcification Effects 0.000 description 5
- 208000008634 oligospermia Diseases 0.000 description 5
- 230000036616 oligospermia Effects 0.000 description 5
- 231100000528 oligospermia Toxicity 0.000 description 5
- 206010067162 Asthenospermia Diseases 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 208000007799 Asthenozoospermia Diseases 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000004720 fertilization Effects 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 230000019100 sperm motility Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 230000000920 spermatogeneic effect Effects 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010050208 Teratospermia Diseases 0.000 description 1
- 208000002312 Teratozoospermia Diseases 0.000 description 1
- 206010043298 Testicular atrophy Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 201000010788 atrophy of testis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 230000034004 oogenesis Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000009933 reproductive health Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 231100001044 testicular atrophy Toxicity 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 244000059546 zoonotic virus Species 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
- A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/30—Hydrogen technology
- Y02E60/50—Fuel cells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明属于辅助生殖技术领域,具体涉及一种人造透明带及制备方法。The invention belongs to the technical field of assisted reproduction, and in particular relates to an artificial zona pellucida and a preparation method.
背景技术Background technique
不孕不育症是严重危害人类生殖健康的重大疾病,世界卫生组织(WHO)预计,21世纪不孕不育症将是仅次于癌症和心血管疾病之后的世界第三大疾病。WHO调查数据显示,全世界不孕不育症发病率约占育龄夫妇10-15%,其中男方因素约占40-50%。男性不孕不育患者中70%是由精液异常导致的,主要表现为少精症、弱精症、少弱精症、畸精症或无精症。据统计,男性中少精症、无精症和弱精症的发病率呈逐年上升趋势。无精症在不孕不育男性中占10%-15%,其中80%为非梗阻性无精症,目前无有效的治疗手段。睾丸显微取精术结合卵泡内单精子注射(ICSI)技术进行体外受精是非梗阻性无精症患者获得遗传学后代唯一的希望。Infertility is a major disease that seriously endangers human reproductive health. The World Health Organization (WHO) predicts that infertility will be the third largest disease in the world after cancer and cardiovascular disease in the 21st century. WHO survey data shows that the incidence of infertility in the world accounts for about 10-15% of couples of childbearing age, of which the male factor accounts for about 40-50%. 70% of male infertility patients are caused by abnormal semen, mainly manifested as oligospermia, asthenozoospermia, oligoasthenospermia, teratospermia or azoospermia. According to statistics, the incidence of oligospermia, azoospermia and asthenospermia in men is increasing year by year. Azoospermia accounts for 10%-15% of infertile men, of which 80% are non-obstructive azoospermia, and there is currently no effective treatment. In vitro fertilization with testicular sperm retrieval combined with intrafollicular sperm injection (ICSI) technology is the only hope for genetic offspring in patients with non-obstructive azoospermia.
临床上ICSI治疗周期的妊娠率仅为50%,为了获得妊娠,部分患者需要重复数次ICSI治疗。由于睾丸取精术是一种有创操作,每次取精都有可能造成睾丸萎缩或睾丸功能进一步下降,进而完全丧失生精功能。为了尽可能地减少患者反复取精的痛苦及避免睾丸生精功能完全丧失,因此有必要对无精症患者诊断性穿刺获得的或ICSI治疗周期剩余的微量活动精子进行冷冻保存,以便在女方取卵日将其复苏用于ICSI治疗,这将大大提高少精症、无精症患者辅助生育治疗的灵活性和可靠性。同时严重少弱精子症患者的精子活力不稳定,预防性冷冻患者的精子也非常必要,这将避免女方取卵日无精子可用而取消周期。因此微量精子冻存是提高妊娠成功率的关键技术。Clinically, the pregnancy rate of ICSI treatment cycle is only 50%. In order to obtain pregnancy, some patients need to repeat ICSI treatment several times. Since testicular sperm retrieval is an invasive operation, each sperm retrieval may cause testicular atrophy or further decline in testicular function, thereby completely losing spermatogenic function. In order to minimize the pain of repeated sperm retrieval and avoid the complete loss of testicular spermatogenic function, it is necessary to cryopreserve the micromotile sperm obtained from diagnostic puncture of azoospermia patients or remaining in the ICSI treatment cycle, so that the sperm can be collected from the woman. It will be resuscitated for ICSI treatment on egg day, which will greatly improve the flexibility and reliability of assisted fertility treatment for patients with oligospermia and azoospermia. At the same time, the sperm motility of patients with severe oligoasthenozoospermia is unstable, and preventive freezing of the sperm of patients is also very necessary, which will prevent the woman from having no sperm available on the egg retrieval day and cancel the cycle. Therefore, micro-sperm cryopreservation is a key technology to improve the success rate of pregnancy.
少量精子冷冻保存是辅助生殖领域的难题,目前还没有比较理想的冷冻保存方法。透明带法是较好的少量精子冻存方法,透明带是包绕在卵母细胞外的一层糖蛋白,在卵子发生、卵子保护、阻止多精受精中发挥着重要的作用。运用显微操作技术清除透明带内容物,然后用ICSI显微注射针将少量精子注入到空透明带内冻存精子。1997年,Walmsley等人报道诞生了第一例用空透明带冷冻睾丸精子受精成功的婴儿,5个周期中3个怀孕,并且其中的5个为双胞胎。空透明带冷冻可以明显提高精子冷冻复苏回收率,维持精子的运动性、染色质和DNA完整性,研究显示透明带冷冻精子冻融回收率为88.3%,ICSI活动精子的受精率达到60%,说明空透明带冷冻对精子的损伤较低,可以为少量或单个精子的冷冻提供很好的保护。2005年,黄荷凤、徐晨明以胞浆抽空的透明带为冷冻保存载体冻存精子,首先将活检的睾丸精子装入封闭的透明带内,然后进行精子冷冻保护剂的添加和洗脱,冻存与复苏过程中精子封闭保存于透明带内,避免了精子的丢失,其精子回收率高达70%,远高于常规冻存法。尽管透明带冷冻的复苏回收率在70%以上,但仍然存在一些问题,如该方法使用的是哺乳动物或人卵的透明带,材料来源困难(人卵透明带很难获得),且存在伦理争议(ICSI治疗时宿主DNA有与精子一起被注入人卵的风险),同时还存在人畜共患病毒感染的危险,所以该方法很难在辅助生殖临床上广泛应用。The cryopreservation of a small amount of sperm is a difficult problem in the field of assisted reproduction, and there is currently no ideal cryopreservation method. The zona pellucida method is a better method for cryopreserving a small amount of sperm. The zona pellucida is a layer of glycoprotein that surrounds the oocyte and plays an important role in oogenesis, egg protection, and preventing polyspermia. The contents of the zona pellucida were removed by micromanipulation, and then a small amount of sperm was injected into the empty zona pellucida with an ICSI microinjection needle for cryopreservation. In 1997, Walmsley et al. reported the birth of the first successful fertilization of infants with spermatozoa from an empty zona pellucida frozen testis, 3 out of 5 cycles, and 5 of them were twins. Empty zona pellucida freezing can significantly improve the recovery rate of sperm cryopreservation, maintain sperm motility, chromatin and DNA integrity. Studies have shown that the freezing and thawing recovery rate of zona pellucida frozen sperm is 88.3%, and the fertilization rate of ICSI motile sperm is 60%. It shows that the freezing of empty zona pellucida has low damage to sperm, and can provide good protection for freezing a small amount or single sperm. In 2005, Huang Hefeng and Xu Chenming used the zona pellucida evacuated from the cytoplasm as a cryopreservation carrier for cryopreservation of sperm. First, the biopsied testicular sperm was put into the closed zona pellucida, and then the sperm cryoprotectant was added and eluted for cryopreservation. During the recovery process, the sperm is sealed and stored in the zona pellucida to avoid the loss of sperm, and the sperm recovery rate is as high as 70%, which is much higher than the conventional cryopreservation method. Although the recovery rate of zona pellucida freezing is above 70%, there are still some problems, such as the method uses the zona pellucida of mammalian or human eggs, the source of materials is difficult (the human egg zona pellucida is difficult to obtain), and there are ethical issues Controversy (the risk of host DNA being injected into human eggs together with sperm during ICSI treatment), and the risk of zoonotic virus infection, it is difficult for this method to be widely used in assisted reproduction.
综上所述,透明带法虽然是较好的少量或单个精子冷冻保存方法,并且精子冻存操作简单、快捷,但是该方法也存在伦理及无法避免DNA或外来异源性蛋白污染等问题,限制了其在临床上的应用。To sum up, although the zona pellucida method is a better method for cryopreservation of a small amount or a single sperm, and the cryopreservation of sperm is simple and fast, this method also has ethical problems and cannot avoid DNA or foreign heterologous protein contamination. limiting its clinical application.
发明内容SUMMARY OF THE INVENTION
有鉴于此,本发明要解决的技术问题在于提供一种人造透明带及制备方法,本发明提供的人造透明带生物相容性良好,对精子活性不产生影响,并且不存在伦理及DNA或外来异源性蛋白污染等问题。In view of this, the technical problem to be solved by the present invention is to provide an artificial zona pellucida and a preparation method. The artificial zona pellucida provided by the present invention has good biocompatibility, does not affect sperm activity, and has no ethics, DNA or foreign Heterologous protein contamination, etc.
本发明提供了一种人造透明带,由海藻酸钠和聚鸟氨酸制备而成。The invention provides an artificial zona pellucida prepared from sodium alginate and polyornithine.
优选的,所述人造透明带为具有中空结构的外壳,所述外壳为海藻酸钠和聚鸟氨酸聚电解质复合膜;Preferably, the artificial transparent belt is an outer shell with a hollow structure, and the outer shell is a composite membrane of sodium alginate and polyornithine polyelectrolyte;
所述人造透明带的尺寸为80~200μm,优选100~150μm;所述人造透明带的膜厚度为5~50μm,优选10~30μm。The size of the artificial transparent belt is 80-200 μm, preferably 100-150 μm; the film thickness of the artificial transparent belt is 5-50 μm, preferably 10-30 μm.
优选的,所述聚鸟氨酸的数均分子量为10kDa~100kDa,优选10kDa~50kDa。Preferably, the polyornithine has a number-average molecular weight of 10 kDa to 100 kDa, preferably 10 kDa to 50 kDa.
本发明还提供了一种上述人造透明带的制备方法,包括以下步骤:The present invention also provides a preparation method of the above-mentioned artificial transparent zona, comprising the following steps:
A)将海藻酸钙水凝胶微球与聚鸟氨酸溶液混合,进行成膜反应,在微球外部形成聚鸟氨酸聚电解质络合膜,得到覆膜水凝胶微球;A) mixing calcium alginate hydrogel microspheres with polyornithine solution, and performing a film-forming reaction to form a polyornithine polyelectrolyte complex membrane on the outside of the microspheres to obtain film-coated hydrogel microspheres;
B)将所述覆膜水凝胶微球与柠檬酸钠溶液混合,进行液化反应,得到具有中空结构的人造透明带。B) Mixing the film-coated hydrogel microspheres with a sodium citrate solution to carry out a liquefaction reaction to obtain an artificial zona pellucida with a hollow structure.
优选的,采用静电液滴法或乳化内部凝胶化法制备海藻酸钙水凝胶微球。Preferably, the calcium alginate hydrogel microspheres are prepared by the electrostatic drop method or the emulsification internal gelation method.
优选的,所述制备海藻酸钙水凝胶微球的原料为海藻酸钠溶液和氯化钙溶液,其中,所述海藻酸钠溶液的粘度为50~200mPa·s,优选80~150mPa·s;氯化钙溶液质量浓度为0.5%~2%,优选0.8%~1.5%。Preferably, the raw materials for preparing calcium alginate hydrogel microspheres are sodium alginate solution and calcium chloride solution, wherein the viscosity of the sodium alginate solution is 50-200 mPa·s, preferably 80-150 mPa·s The mass concentration of the calcium chloride solution is 0.5% to 2%, preferably 0.8% to 1.5%.
优选的,所述聚鸟氨酸溶液的质量浓度为0.01%~3%,优选质量浓度为0.05%~2%。Preferably, the mass concentration of the polyornithine solution is 0.01% to 3%, and the preferred mass concentration is 0.05% to 2%.
优选的,步骤A)中,所述反应的温度为室温,所述反应的时间为1~20min,优选为3~10min。Preferably, in step A), the reaction temperature is room temperature, and the reaction time is 1-20 min, preferably 3-10 min.
优选的,所述柠檬酸钠浓度为30~70mM,优选40~60mM。Preferably, the sodium citrate concentration is 30-70 mM, preferably 40-60 mM.
优选的,所述液化反应的时间为5~30min,优选为10~20min;所述液化反应的温度为室温。Preferably, the time of the liquefaction reaction is 5-30 minutes, preferably 10-20 minutes; the temperature of the liquefaction reaction is room temperature.
与现有技术相比,本发明提供了一种人造透明带,由海藻酸钠和聚鸟氨酸制备而成。本发明提供的人造透明带可以将少量精子(包括单个精子)保存在内核空腔内,有效避免了精子丢失,并且所用材料生物相容性良好,对精子活性不产生影响,并且不存在伦理及DNA或外来异源性蛋白污染等问题。Compared with the prior art, the present invention provides an artificial zona pellucida prepared from sodium alginate and polyornithine. The artificial zona pellucida provided by the present invention can store a small amount of sperm (including single sperm) in the inner core cavity, effectively avoid sperm loss, and the materials used have good biocompatibility, have no impact on sperm activity, and have no ethical and DNA or foreign heterologous protein contamination and other issues.
附图说明Description of drawings
图1为实施例1制备的人造透明带的显微镜图片;Fig. 1 is the microscope picture of the artificial zona pellucida prepared by embodiment 1;
图2为装载精子的人造透明带。Figure 2 shows the artificial zona pellucida loaded with sperm.
具体实施方式Detailed ways
本发明提供了一种人造透明带,由海藻酸钠和聚鸟氨酸制备而成。The invention provides an artificial zona pellucida prepared from sodium alginate and polyornithine.
在本发明中,所述人造透明带为具有中空结构的外壳,所述外壳为海藻酸钠和聚鸟氨酸聚电解质复合膜。In the present invention, the artificial transparent zone is a shell with a hollow structure, and the shell is a composite membrane of sodium alginate and polyornithine polyelectrolyte.
所述人造透明带的尺寸为80~200μm,优选100~150μm;所述人造透明带的膜厚度为5~50μm,优选10~30μm。The size of the artificial transparent belt is 80-200 μm, preferably 100-150 μm; the film thickness of the artificial transparent belt is 5-50 μm, preferably 10-30 μm.
所述聚鸟氨酸的分子量为10kDa~100kDa,优选10kDa~50kDa。The molecular weight of the polyornithine is 10kDa-100kDa, preferably 10kDa-50kDa.
本发明还提供了一种上述人造透明带的制备方法,包括以下步骤:The present invention also provides a preparation method of the above-mentioned artificial transparent zona, comprising the following steps:
A)将海藻酸钙水凝胶微球与聚鸟氨酸溶液混合,进行成膜反应,在微球外部形成聚鸟氨酸聚电解质络合膜,得到覆膜水凝胶微球;A) mixing calcium alginate hydrogel microspheres with polyornithine solution, and performing a film-forming reaction to form a polyornithine polyelectrolyte complex membrane on the outside of the microspheres to obtain film-coated hydrogel microspheres;
B)将所述覆膜水凝胶微球与柠檬酸钠溶液混合,进行液化反应,得到具有中空结构的人造透明带。B) Mixing the film-coated hydrogel microspheres with a sodium citrate solution to carry out a liquefaction reaction to obtain an artificial zona pellucida with a hollow structure.
本发明首先制备海藻酸钙水凝胶微球,本发明对所述海藻酸钙水凝胶微球的制备方法并没有特殊限制,本领域技术人员公知的方法即可。优选的,本发明采用静电液滴法或乳化内部凝胶化法制备海藻酸钙水凝胶微球。The present invention firstly prepares calcium alginate hydrogel microspheres. The present invention has no special limitation on the preparation method of the calcium alginate hydrogel microspheres, and the method known to those skilled in the art may be sufficient. Preferably, the present invention adopts electrostatic droplet method or emulsification internal gelation method to prepare calcium alginate hydrogel microspheres.
所述制备海藻酸钙水凝胶微球的原料为海藻酸钠溶液和氯化钙溶液,其中,所述海藻酸钠溶液的粘度为50~200mPa·s,优选80~150mPa·s;氯化钙溶液质量浓度为0.5%~2%,优选0.8%~1.5%。制备水凝胶微球钙化的时间为10~30min,优选15~25min;微球制备温度室温。The raw materials for preparing calcium alginate hydrogel microspheres are sodium alginate solution and calcium chloride solution, wherein the viscosity of the sodium alginate solution is 50-200 mPa·s, preferably 80-150 mPa·s; The mass concentration of the calcium solution is 0.5% to 2%, preferably 0.8% to 1.5%. The calcification time for preparing the hydrogel microspheres is 10-30 minutes, preferably 15-25 minutes; the preparation temperature of the microspheres is room temperature.
得到海藻酸钙水凝胶微球后,将海藻酸钙水凝胶微球与聚鸟氨酸溶液混合,进行成膜反应,在微球外部形成聚鸟氨酸聚电解质络合膜,得到覆膜水凝胶微球。其中,聚鸟氨酸分子量为10kDa~100kDa,优选10kDa~50kDa,溶液质量浓度为0.01%~3%,优选质量浓度为0.05%~2%;反应时间为1~20min,优选反应时间为3~10min;反应温度为室温。After the calcium alginate hydrogel microspheres are obtained, the calcium alginate hydrogel microspheres are mixed with the polyornithine solution, and a film-forming reaction is carried out to form a polyornithine polyelectrolyte complex membrane outside the microspheres to obtain a coating. Membrane hydrogel microspheres. Wherein, the molecular weight of polyornithine is 10kDa~100kDa, preferably 10kDa~50kDa, the mass concentration of the solution is 0.01%~3%, and the preferred mass concentration is 0.05%~2%; the reaction time is 1~20min, and the preferred reaction time is 3~3% 10min; the reaction temperature is room temperature.
将所述覆膜水凝胶微球与柠檬酸钠溶液混合,进行液化反应,得到具有中空结构的人造透明带。其中,The film-coated hydrogel microspheres are mixed with a sodium citrate solution to carry out a liquefaction reaction to obtain an artificial zona pellucida with a hollow structure. in,
所述柠檬酸钠溶液的浓度为30~70mM,优选为40~60mM;液化时间5~30min,优化10~20min;反应温度为室温。The concentration of the sodium citrate solution is 30-70 mM, preferably 40-60 mM; the liquefaction time is 5-30 min, optimized for 10-20 min; the reaction temperature is room temperature.
本发明提供的人造透明带用于冷冻保存精子活性高的少量精子,含单个精子,如睾丸穿刺精子、附睾穿刺精子、严重少精和弱精症患者的精子等。The artificial zona pellucida provided by the invention is used for cryopreserving a small amount of sperm with high sperm motility, including single sperm, such as testicular puncture sperm, epididymal puncture sperm, sperm from patients with severe oligospermia and asthenozoospermia, and the like.
本发明提供了一种可用于少量精子冷冻保存的人造透明带及制备方法,旨在提供一种体积较小的、具有封闭空间、易于操作、精子活性高的适合少量精子冷冻保存(含单个精子,如睾丸穿刺精子、附睾穿刺精子、严重少精和弱精症患者的精子等)的人造透明带。The invention provides an artificial zona pellucida that can be used for cryopreservation of a small amount of sperm and a preparation method, and aims to provide a small volume, closed space, easy operation and high sperm activity suitable for cryopreservation of a small amount of sperm (including single sperm , such as testicular puncture sperm, epididymal puncture sperm, sperm from patients with severe oligospermia and asthenozoospermia, etc.) artificial zona pellucida.
本发明提供的技术方案具有如下的技术优点:The technical scheme provided by the present invention has the following technical advantages:
1、本发明提供的人造透明带所用材料无毒、生物相容性良好,对装载的精子无影响,有利于保持精子的活性。1. The materials used in the artificial zona pellucida provided by the present invention are non-toxic, have good biocompatibility, have no effect on the loaded sperm, and are conducive to maintaining the activity of the sperm.
2、本发明提供的人造透明带体积较小,在显微操作时很容易找到并抓取精子,有利于保持精子的活性。2. The artificial zona pellucida provided by the present invention has a small volume, and it is easy to find and grab sperm during micromanipulation, which is beneficial to maintain the activity of the sperm.
3、本发明提供的人造透明带强度较高,冻存后形态不变,依然保持完整,有效避免了精子在冻存及复苏过程中的丢失,精子回收率高。3. The artificial zona pellucida provided by the present invention has high strength, the shape remains intact after cryopreservation, effectively avoids the loss of sperm during cryopreservation and recovery, and has a high sperm recovery rate.
4、本发明提供的人造透明带制备工艺简单,易于放大和工业化生产。4. The artificial transparent zona provided by the present invention has a simple preparation process, and is easy to enlarge and industrialize production.
为了进一步理解本发明,下面结合实施例对本发明提供的人造透明带及制备方法进行说明,本发明的保护范围不受以下实施例的限制。In order to further understand the present invention, the artificial transparent tape provided by the present invention and the preparation method are described below with reference to the examples, and the protection scope of the present invention is not limited by the following examples.
实施例1Example 1
本发明提供的一种可用于少量精子冷冻保存的人造透明带及制备方法,The invention provides an artificial zona pellucida that can be used for cryopreservation of a small amount of sperm and a preparation method thereof,
1、聚鸟氨酸人造透明带制备1. Preparation of polyornithine artificial zona pellucida
(1)配制质量浓度为1.2%的海藻酸钠溶液,粘度计测定粘度为90.3mPa·s,采用静电液滴法将海藻酸钠溶液滴入质量浓度为1.1%的氯化钙溶液中形成海藻酸钙水凝胶微球,钙化30min后去除氯化钙溶液;(1) Prepare a sodium alginate solution with a mass concentration of 1.2%, the viscosity measured by a viscometer is 90.3 mPa·s, and drop the sodium alginate solution into a calcium chloride solution with a mass concentration of 1.1% by electrostatic drop method to form seaweed Calcium acid hydrogel microspheres, calcium chloride solution is removed after calcification for 30min;
(2)将海藻酸钙水凝胶微球加入到质量浓度为0.1%的聚鸟氨酸(数均分子量22kD)溶液中进行成膜反应,搅拌条件下反应10min,在微球外部形成聚电解质络合膜,去离子水清洗去除未反应的聚鸟氨酸;(2) The calcium alginate hydrogel microspheres were added to the polyornithine (number-average molecular weight 22kD) solution with a mass concentration of 0.1% to carry out a film-forming reaction, and the reaction was carried out under stirring conditions for 10 minutes to form a polyelectrolyte outside the microspheres The complex membrane was washed with deionized water to remove unreacted polyornithine;
(3)将清洗干净的覆膜微球加入到质量浓度为1.4%的柠檬酸钠溶液中液化5min,完全液化内部凝胶形成中空结构,去离子水清洗微球去除柠檬酸钠溶液,即得中空人造透明带。(3) The cleaned coated microspheres were added to a sodium citrate solution with a mass concentration of 1.4% to liquefy for 5 minutes, the internal gel was completely liquefied to form a hollow structure, and the microspheres were washed with deionized water to remove the sodium citrate solution, that is, Hollow artificial transparent belt.
2、精子冷冻保存2. Sperm cryopreservation
冷冻时,先吸取1滴精子培养液(含30个精子)放置于精子培养皿中形成一个液滴(约0.5μl),然后加入10ml矿物油覆盖液滴,吸取30个中空微球载体放入精子培养液液滴中,用显微注射针抓取1个活动精子置入1个冷冻保存载体中,用吸管吸取30个冷冻保存载体放入的冻存管,冷存管内添加精子冻存液,液氮面上方4cm高度的液氮蒸汽预冷降温3min(降温速度20℃/min)后,将冷冻管投入液氮中进行快速冷冻并保存。When freezing, first draw 1 drop of sperm culture solution (containing 30 sperm) and place it in a sperm culture dish to form a drop (about 0.5 μl), then add 10 ml of mineral oil to cover the drop, and draw 30 hollow microsphere carriers into the In the droplet of sperm culture solution, use a microinjection needle to grab 1 motile sperm and place it into 1 cryopreservation carrier, suck 30 cryopreservation tubes into the cryopreservation tube with a pipette, and add sperm cryopreservation solution to the cryopreservation tube. , after the liquid nitrogen vapor at a height of 4 cm above the liquid nitrogen surface was pre-cooled for 3 minutes (cooling rate of 20 ° C/min), the freezing tube was put into liquid nitrogen for rapid freezing and storage.
3、精子复苏3. Sperm recovery
复苏时,自液氮罐中取出冷冻管,37℃快速解冻,用吸管将含微球载体的冻存液从冷冻管内取出,迅速加入到培养皿(含37℃的精子培养液5ml)中,在冷冻载体内寻找精子,用显微注射针抓取精子转入另一个含精子培养基的培养皿中,用于后续精子制动和成熟卵子的ICSI,参见图2,图2为装载精子的人造透明带。When resuscitated, take out the cryovial from the liquid nitrogen tank, thaw it quickly at 37°C, take out the cryopreservation solution containing the microsphere carrier from the cryotube with a pipette, and quickly add it to the petri dish (containing 5ml of sperm culture solution at 37°C), Look for sperm in the frozen carrier, grab the sperm with a microinjection needle and transfer it to another petri dish containing sperm medium for subsequent sperm immobilization and ICSI of mature eggs, see Figure 2, Figure 2 shows the loaded sperm Artificial transparent belt.
参见图1,图1为实施例1制备的人造透明带的显微镜图片,其中,微球粒径130μm,膜厚度15μm;冻存后人造透明带完整率100%,精子回收率100%,精子存活率93.3%;人卵透明带冷冻保存完整率100%,精子回收率100%,精子存活率86.7%,与人造透明带无显著性差异。Referring to Fig. 1, Fig. 1 is a microscope picture of the artificial zona pellucida prepared in Example 1, wherein the particle size of the microspheres is 130 μm, and the film thickness is 15 μm; after cryopreservation, the integrity rate of the artificial zona pellucida is 100%, the sperm recovery rate is 100%, and the sperm survives. The complete rate of cryopreservation of human egg zona pellucida is 100%, sperm recovery rate is 100%, sperm survival rate is 86.7%, and there is no significant difference between artificial zona pellucida and artificial zona pellucida.
实施例2Example 2
本发明提供的一种可用于少量精子冷冻保存的人造透明带及制备方法,The invention provides an artificial zona pellucida that can be used for cryopreservation of a small amount of sperm and a preparation method thereof,
1、聚鸟氨酸人造透明带制备1. Preparation of polyornithine artificial zona pellucida
(1)配制质量浓度为1.5%的海藻酸钠溶液,粘度计测定粘度为90.6mPa·s,采用静电液滴法将海藻酸钠溶液滴入质量浓度为1.1%的氯化钙溶液中形成海藻酸钙水凝胶微球,钙化30min后去除氯化钙溶液;(1) Prepare a sodium alginate solution with a mass concentration of 1.5%, the viscosity measured by a viscometer is 90.6 mPa·s, and the sodium alginate solution is dropped into a calcium chloride solution with a mass concentration of 1.1% by the electrostatic drop method to form seaweed Calcium acid hydrogel microspheres, calcium chloride solution is removed after calcification for 30min;
(2)将海藻酸钙水凝胶微球加入到质量浓度为0.1%的聚鸟氨酸(数均分子量22kD)溶液中进行成膜反应,搅拌条件下反应8min,在微球外部形成聚电解质络合膜,去离子水清洗去除未反应的聚鸟氨酸;(2) The calcium alginate hydrogel microspheres were added to the polyornithine (number-average molecular weight 22kD) solution with a mass concentration of 0.1% to carry out a film-forming reaction, and the reaction was carried out under stirring conditions for 8 minutes to form a polyelectrolyte outside the microspheres The complex membrane was washed with deionized water to remove unreacted polyornithine;
(3)将清洗干净的覆膜微球加入到质量浓度为1.4%的柠檬酸钠溶液中液化5min,完全液化内部凝胶形成中空结构,去离子水清洗微球去除柠檬酸钠溶液,即得中空人造透明带。(3) The cleaned coated microspheres were added to a sodium citrate solution with a mass concentration of 1.4% to liquefy for 5 minutes, the internal gel was completely liquefied to form a hollow structure, and the microspheres were washed with deionized water to remove the sodium citrate solution, that is, Hollow artificial transparent belt.
2、精子冷冻保存2. Sperm cryopreservation
冷冻时,先吸取1滴精子培养液(含30个精子)放置于精子培养皿中形成一个液滴(约0.5μl),然后加入10ml矿物油覆盖液滴,吸取30个中空微球载体放入精子培养液液滴中,用显微注射针抓取1个活动精子置入1个冷冻保存载体中,用吸管吸取10个冷冻保存载体放入的冻存管,冷存管内添加精子冻存液,液氮面上方4cm高度的液氮蒸汽预冷降温3min(降温速度20℃/min)后,将冷冻管投入液氮中进行快速冷冻并保存。When freezing, first draw 1 drop of sperm culture solution (containing 30 sperm) and place it in a sperm culture dish to form a drop (about 0.5 μl), then add 10 ml of mineral oil to cover the drop, and draw 30 hollow microsphere carriers into the In the droplet of sperm culture solution, use a microinjection needle to grab 1 motile sperm and place it into 1 cryopreservation carrier, use a pipette to suck up the cryopreservation tube into which 10 cryopreservation carriers are placed, and add sperm cryopreservation solution to the cryopreservation tube. , after the liquid nitrogen vapor at a height of 4 cm above the liquid nitrogen surface was pre-cooled for 3 minutes (cooling rate of 20 ° C/min), the freezing tube was put into liquid nitrogen for rapid freezing and storage.
(3)精子复苏(3) Sperm recovery
复苏时,自液氮罐中取出冷冻管,37℃快速解冻,用吸管将含微球载体的冻存液从冷冻管内取出,迅速加入到培养皿(含37℃的精子培养液5ml)中,在冷冻载体内寻找精子,用显微注射针抓取精子转入另一个含精子培养基的培养皿中,用于后续精子制动和成熟卵子的ICSI。When resuscitated, take out the cryovial from the liquid nitrogen tank, thaw it quickly at 37°C, take out the cryopreservation solution containing the microsphere carrier from the cryotube with a pipette, and quickly add it to the petri dish (containing 5ml of sperm culture solution at 37°C), Search for sperm in the frozen carrier, grab the sperm with a microinjection needle and transfer it to another petri dish containing sperm medium for subsequent sperm immobilization and ICSI of mature eggs.
微球粒径200μm,膜厚度15μm;冻存后微球完整率90%,精子回收率86.7%,精子存活率82.4%。The particle size of the microspheres was 200 μm, and the membrane thickness was 15 μm; after cryopreservation, the integrity rate of the microspheres was 90%, the sperm recovery rate was 86.7%, and the sperm survival rate was 82.4%.
实施例3Example 3
本发明提供的一种可用于少量精子冷冻保存的人造透明带及制备方法,The invention provides an artificial zona pellucida that can be used for cryopreservation of a small amount of sperm and a preparation method thereof,
1、聚鸟氨酸人造透明带制备1. Preparation of polyornithine artificial zona pellucida
(1)配制质量浓度为1.8%的海藻酸钠溶液,粘度计测定粘度为180.9.mPa·s,,采用静电液滴法将海藻酸钠溶液滴入质量浓度为1.1%的氯化钙溶液中形成海藻酸钙水凝胶微球,钙化30min后去除氯化钙溶液;(1) The sodium alginate solution with a mass concentration of 1.8% was prepared, and the viscosity measured by the viscometer was 180.9.mPa·s, and the sodium alginate solution was dropped into the calcium chloride solution with a mass concentration of 1.1% by the electrostatic drop method. Calcium alginate hydrogel microspheres are formed, and the calcium chloride solution is removed after calcification for 30 minutes;
(2)将海藻酸钙水凝胶微球加入到质量浓度为0.1%的聚鸟氨酸(数均分子量22kD)溶液中进行成膜反应,搅拌条件下反应8min后形成微球外壳,去离子水清洗微球去除聚鸟氨酸溶液;(2) The calcium alginate hydrogel microspheres were added to the polyornithine (number-average molecular weight 22kD) solution with a mass concentration of 0.1% to carry out a film-forming reaction. Wash the microspheres with water to remove the polyornithine solution;
(3)将清洗干净的覆膜微球加入到质量浓度为1.4%的柠檬酸钠溶液中液化5min,完全液化内部凝胶形成中空结构,去离子水清洗微球去除柠檬酸钠溶液,即得中空人造透明带。(3) The cleaned coated microspheres were added to a sodium citrate solution with a mass concentration of 1.4% to liquefy for 5 minutes, the internal gel was completely liquefied to form a hollow structure, and the microspheres were washed with deionized water to remove the sodium citrate solution, that is, Hollow artificial transparent belt.
2、精子冷冻保存2. Sperm cryopreservation
冷冻时,先吸取1滴精子培养液(含40个精子)放置于精子培养皿中形成一个液滴(约0.5μl),然后加入10ml矿物油覆盖液滴,吸取20个中空微球载体放入精子培养液液滴中,用显微注射针抓取10个活动精子置入1个冷冻保存载体中,用吸管吸取10个冷冻保存载体放入的冻存管,冷存管内添加精子冻存液,液氮面上方4cm高度的液氮蒸汽预冷降温3min(降温速度20℃/min)后,将冷冻管投入液氮中进行快速冷冻并保存。When freezing, first draw 1 drop of sperm culture solution (containing 40 sperm) and place it in a sperm culture dish to form a drop (about 0.5 μl), then add 10 ml of mineral oil to cover the drop, and draw 20 hollow microsphere carriers into the In the droplets of sperm culture solution, use a microinjection needle to grab 10 motile sperm and place them in a cryopreservation carrier, use a pipette to aspirate the cryopreservation tube into which 10 cryopreservation carriers are placed, and add sperm cryopreservation solution to the cryopreservation tube. , after the liquid nitrogen vapor at a height of 4 cm above the liquid nitrogen surface was pre-cooled for 3 minutes (cooling rate of 20 ° C/min), the freezing tube was put into liquid nitrogen for rapid freezing and storage.
(3)精子复苏(3) Sperm recovery
复苏时,自液氮罐中取出冷冻管,37℃快速解冻,用吸管将含微球载体的冻存液从冷冻管内取出,迅速加入到培养皿(含37℃的精子培养液5ml)中,在冷冻载体内寻找精子,用显微注射针抓取精子转入另一个含精子培养基的培养皿中,用于后续精子制动和成熟卵子的ICSI。When resuscitated, take out the cryovial from the liquid nitrogen tank, thaw it quickly at 37°C, take out the cryopreservation solution containing the microsphere carrier from the cryotube with a pipette, and quickly add it to the petri dish (containing 5ml of sperm culture solution at 37°C), Search for sperm in the frozen carrier, grab the sperm with a microinjection needle and transfer it to another petri dish containing sperm medium for subsequent sperm immobilization and ICSI of mature eggs.
微球粒径280μm,膜厚度15μm;冻存后微球完整率65%,精子回收率62.5%,精子存活率55%。The particle size of the microspheres was 280 μm, and the film thickness was 15 μm; after cryopreservation, the integrity rate of the microspheres was 65%, the sperm recovery rate was 62.5%, and the sperm survival rate was 55%.
实施例4Example 4
本发明提供的一种可用于少量精子冷冻保存的人造透明带及制备方法,The invention provides an artificial zona pellucida that can be used for cryopreservation of a small amount of sperm and a preparation method thereof,
1、聚鸟氨酸人造透明带制备1. Preparation of polyornithine artificial zona pellucida
(1)配制质量浓度为1.5%的海藻酸钠溶液,粘度计测定粘度为90.6mPa·s,采用静电液滴法将海藻酸钠溶液滴入质量浓度为1.1%的氯化钙溶液中形成海藻酸钙水凝胶微球,钙化30min后去除氯化钙溶液;(1) Prepare a sodium alginate solution with a mass concentration of 1.5%, the viscosity measured by a viscometer is 90.6 mPa·s, and the sodium alginate solution is dropped into a calcium chloride solution with a mass concentration of 1.1% by the electrostatic drop method to form seaweed Calcium acid hydrogel microspheres, calcium chloride solution is removed after calcification for 30min;
(2)将海藻酸钙水凝胶微球加入到质量浓度为0.1%的聚鸟氨酸(数均分子量63kD)溶液中进行成膜反应,搅拌条件下反应12min,在微球外部形成聚电解质络合膜,去离子水清洗去除未反应的聚鸟氨酸;(2) The calcium alginate hydrogel microspheres were added to the polyornithine (number-average molecular weight 63kD) solution with a mass concentration of 0.1% to carry out a film-forming reaction, and the reaction was carried out under stirring conditions for 12 minutes to form a polyelectrolyte outside the microspheres The complex membrane was washed with deionized water to remove unreacted polyornithine;
(3)将清洗干净的覆膜微球加入到质量浓度为1.4%的柠檬酸钠溶液中液化5min,完全液化内部凝胶形成中空结构,去离子水清洗微球去除柠檬酸钠溶液,即得中空人造透明带。(3) The cleaned coated microspheres were added to a sodium citrate solution with a mass concentration of 1.4% to liquefy for 5 minutes, the internal gel was completely liquefied to form a hollow structure, and the microspheres were washed with deionized water to remove the sodium citrate solution, that is, Hollow artificial transparent belt.
2、精子冷冻保存2. Sperm cryopreservation
冷冻时,先吸取1滴精子培养液(含30个精子)放置于精子培养皿中形成一个液滴(约0.5μl),然后加入10ml矿物油覆盖液滴,吸取30个中空微球载体放入精子培养液液滴中,用显微注射针抓取1个活动精子置入1个冷冻保存载体中,用吸管吸取10个冷冻保存载体放入的冻存管,冷存管内添加精子冻存液,液氮面上方4cm高度的液氮蒸汽预冷降温3min(降温速度20℃/min)后,将冷冻管投入液氮中进行快速冷冻并保存。When freezing, first draw 1 drop of sperm culture solution (containing 30 sperm) and place it in a sperm culture dish to form a drop (about 0.5 μl), then add 10 ml of mineral oil to cover the drop, and draw 30 hollow microsphere carriers into the In the droplet of sperm culture solution, use a microinjection needle to grab 1 motile sperm and place it into 1 cryopreservation carrier, use a pipette to suck up the cryopreservation tube into which 10 cryopreservation carriers are placed, and add sperm cryopreservation solution to the cryopreservation tube. , after the liquid nitrogen vapor at a height of 4 cm above the liquid nitrogen surface was pre-cooled and cooled for 3 minutes (cooling rate of 20 °C/min), the freezing tube was put into liquid nitrogen for rapid freezing and storage.
(3)精子复苏(3) Sperm recovery
复苏时,自液氮罐中取出冷冻管,37℃快速解冻,用吸管将含微球载体的冻存液从冷冻管内取出,迅速加入到培养皿(含37℃的精子培养液5ml)中,在冷冻载体内寻找精子,用显微注射针抓取精子转入另一个含精子培养基的培养皿中,用于后续精子制动和成熟卵子的ICSI。When resuscitated, take out the cryovial from the liquid nitrogen tank, thaw it quickly at 37°C, take out the cryopreservation solution containing the microsphere carrier from the cryotube with a pipette, and quickly add it to the petri dish (containing 5ml of sperm culture solution at 37°C), Search for sperm in the frozen carrier, grab the sperm with a microinjection needle and transfer it to another petri dish containing sperm medium for subsequent sperm immobilization and ICSI of mature eggs.
微球粒径200μm,膜厚度10μm;冻存后微球完整率67.3%,精子回收率66.4%,精子存活率62.2%。The particle size of the microspheres was 200 μm, and the film thickness was 10 μm; after cryopreservation, the integrity rate of the microspheres was 67.3%, the sperm recovery rate was 66.4%, and the sperm survival rate was 62.2%.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention. It should be pointed out that for those skilled in the art, without departing from the principles of the present invention, several improvements and modifications can be made. It should be regarded as the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110260524.4A CN112956473B (en) | 2021-03-10 | 2021-03-10 | Artificial transparent belt and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110260524.4A CN112956473B (en) | 2021-03-10 | 2021-03-10 | Artificial transparent belt and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112956473A true CN112956473A (en) | 2021-06-15 |
| CN112956473B CN112956473B (en) | 2023-05-26 |
Family
ID=76277088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110260524.4A Active CN112956473B (en) | 2021-03-10 | 2021-03-10 | Artificial transparent belt and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112956473B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6365385B1 (en) * | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
| US20030054035A1 (en) * | 2001-09-14 | 2003-03-20 | Benjamin Chu | Cell storage and delivery system |
| CN1566339A (en) * | 2003-07-03 | 2005-01-19 | 中国人民解放军军事医学科学院基础医学研究所 | Device for making microencapsulation cell |
| CN103239730A (en) * | 2013-04-10 | 2013-08-14 | 中国人民解放军第三〇九医院 | Medical sodium alginate gel microsphere and preparation method and application thereof |
| CN106399291A (en) * | 2015-07-27 | 2017-02-15 | 中国科学院大连化学物理研究所 | Galactosyl grafted-modified alginate microspheres and applications thereof |
| CN106860422A (en) * | 2015-12-10 | 2017-06-20 | 中国科学院大连化学物理研究所 | Alginic acid alkali-polycation microcapsules and its for bioactivator embedding |
| CN108207931A (en) * | 2017-12-05 | 2018-06-29 | 中国科学院大连化学物理研究所 | A kind of micro sperm cryopreservation method |
-
2021
- 2021-03-10 CN CN202110260524.4A patent/CN112956473B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6365385B1 (en) * | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
| US20030054035A1 (en) * | 2001-09-14 | 2003-03-20 | Benjamin Chu | Cell storage and delivery system |
| CN1566339A (en) * | 2003-07-03 | 2005-01-19 | 中国人民解放军军事医学科学院基础医学研究所 | Device for making microencapsulation cell |
| CN103239730A (en) * | 2013-04-10 | 2013-08-14 | 中国人民解放军第三〇九医院 | Medical sodium alginate gel microsphere and preparation method and application thereof |
| CN106399291A (en) * | 2015-07-27 | 2017-02-15 | 中国科学院大连化学物理研究所 | Galactosyl grafted-modified alginate microspheres and applications thereof |
| CN106860422A (en) * | 2015-12-10 | 2017-06-20 | 中国科学院大连化学物理研究所 | Alginic acid alkali-polycation microcapsules and its for bioactivator embedding |
| CN108207931A (en) * | 2017-12-05 | 2018-06-29 | 中国科学院大连化学物理研究所 | A kind of micro sperm cryopreservation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112956473B (en) | 2023-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110050782A (en) | A kind of stem cell cryopreserving liquid and preparation method thereof and cryopreservation methods | |
| Mukaida et al. | Vitrification of human embryos based on the assessment of suitable conditions for 8-cell mouse embryos. | |
| Lassalle et al. | Human embryo features that influence the success of cryopreservation with the use of 1, 2 propanediol | |
| Dinnyés et al. | Timing of the first cleavage post‐insemination affects cryosurvival of in vitro–produced bovine blastocysts | |
| CN111789105B (en) | Application of an amino acid cryopreservation solution in stem cell cryopreservation | |
| CN108207931B (en) | Method for freezing and preserving trace sperms | |
| CN107232185B (en) | A kind of equine oocyte vitrification cryopreservation liquid, cryopreservation method and application | |
| CN109315386A (en) | A kind of cryopreservation solution and cryopreservation method that can be used for hematopoietic stem cells or lymphocytes | |
| Wang et al. | Outcomes of day 3 embryo transfer with vitrification using Cryoleaf: a 3-year follow-up study | |
| CN114073249B (en) | Slow quick freezing method for human T lymphocyte | |
| Chang et al. | Two successful pregnancies obtained following oocyte vitrification and embryo re-vitrification | |
| CN112956473B (en) | Artificial transparent belt and preparation method thereof | |
| CN111226910A (en) | Vitrification refrigerating fluid and freezing method for ovum or embryo in cleavage stage | |
| CN114403127B (en) | Mesenchymal stem cell refrigeration protection solution and preservation method | |
| CN202873662U (en) | Embryo vitrification device capable of simultaneously freezing multiple tubes in assisted reproductive technology | |
| CN117941677A (en) | Product for freezing embryo and application thereof | |
| CN108293980B (en) | A vitrified cryopreservation/resuscitation method for neural stem cell spheroids | |
| CN111789102B (en) | Application of thawing solution in thawing frozen and preserved oocyte or embryo | |
| CN216674457U (en) | A micro-sperm cryopreservation device | |
| Miller et al. | In vitro development and implantation rates of fresh and cryopreserved sibling zygotes | |
| CN116135231B (en) | Ice crystal regulator and preparation method and application thereof | |
| CN111657264A (en) | T lymphocyte cryopreservation solution, preparation method thereof and cell cryopreservation method | |
| Siebzehrübl et al. | Pregnancy after in vitro fertilization, cryopreservation, and embryo transfer | |
| CN111226908A (en) | A kind of cell cryopreservation liquid and its preparation method and application | |
| CN101215548B (en) | Human oocyte sequence vitrification refrigerating fluid and melting fluid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: Room 208, 2nd Floor, G1 Building, Phase II, Beihu Science and Technology Industrial Park, Beihu Science and Technology Development Zone, Changchun City, Jilin Province, 130000 Applicant after: Zhongke Qiangshen (Jilin) Technology Co.,Ltd. Address before: 136000 room 208, 2 / F, G1 building, phase II, Beihu science and Technology Industrial Park, Beihu science and Technology Development Zone, Changchun City, Jilin Province Applicant before: JILIN QIANGSHENG BIO-TECH Co.,Ltd. |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |